The New England journal of medicine
-
Randomized Controlled Trial Multicenter Study
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Antiretroviral preexposure prophylaxis is a promising approach for preventing human immunodeficiency virus type 1 (HIV-1) infection in heterosexual populations. ⋯ Oral TDF and TDF-FTC both protect against HIV-1 infection in heterosexual men and women. (Funded by the Bill and Melinda Gates Foundation; Partners PrEP ClinicalTrials.gov number, NCT00557245.).